Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
11/13/2001 | US6316219 Compounds |
11/13/2001 | US6316217 Activin receptor-like kinases, proteins having serine threonine kinase domains and polynucleotides encoding same |
11/13/2001 | US6316208 Methods for determining isolated p27 protein levels and uses thereof |
11/13/2001 | US6316203 Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
11/13/2001 | US6315998 Administering anti-cd40 monoclonal antibody or an antigen binding fragment which is being free of significant agonistic activity and binding to a human cd40 antigen located on surface of a human b cell prevents growth or differentiation |
11/13/2001 | US6315995 Adding to blood inactive recombinant mutein comprising proteolytically inactive mutein of factor ix or ixa to inhibit clot formation, does not interfere with hemostasis when the blood is administered to a patient |
11/13/2001 | US6315988 Reacting dihydroxyphenylalanine or tyrosine with an oxidant enzyme in an acidic medium in the presence of a protein and/or peptide |
11/10/2001 | CA2347151A1 Method for screening a substance having promoting activity on hair growth |
11/08/2001 | WO2001083806A1 Immunoglobulin binding protein arrays in plant cells |
11/08/2001 | WO2001083805A2 Improved e. coli extract for protein synthesis |
11/08/2001 | WO2001083804A2 A method for improving recombinant protein stability and solubility |
11/08/2001 | WO2001083785A2 Regulated antigen delivery system (rads) involving bacteria |
11/08/2001 | WO2001083775A2 Proteases |
11/08/2001 | WO2001083771A2 Human phospholipase c delta 5 |
11/08/2001 | WO2001083750A2 Dendritic cell co-stimulator molecules |
11/08/2001 | WO2001083749A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
11/08/2001 | WO2001083744A2 Natrium-calcium exchanger protein |
11/08/2001 | WO2001083718A1 Mutant strains capable of producing chemically diversified proteins by incorporation of non-conventional amino acids |
11/08/2001 | WO2001083707A2 Chondrocyte cultures and anti-angiogenic fractions therefrom |
11/08/2001 | WO2001083701A2 Light-driven energy generation using proteorhodopsin |
11/08/2001 | WO2001083560A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
11/08/2001 | WO2001083555A2 Pain signaling molecules |
11/08/2001 | WO2001083543A1 Human wingless-like gene |
11/08/2001 | WO2001083530A1 Porphyromonas gingivalis recombinant proteins and truncations |
11/08/2001 | WO2001083527A2 Glucagon antagonists |
11/08/2001 | WO2001083525A2 Modified peptides, comprising an fc domain, as therapeutic agents |
11/08/2001 | WO2001083524A2 Rna metabolism proteins |
11/08/2001 | WO2001083516A1 Laminin 15 and uses thereof |
11/08/2001 | WO2001082944A1 Methods and compositions for impairing multiplication of hiv-1 |
11/08/2001 | WO2001082901A1 New antibodies to biological membranes |
11/08/2001 | WO2001038872A3 Assay of isomerised and/or optically inverted proteins |
11/08/2001 | WO2001038348A3 G-protein coupled receptor htogh35 |
11/08/2001 | WO2001036630A3 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
11/08/2001 | WO2001036489A3 Erythropoietin forms with improved properties |
11/08/2001 | WO2001036485A3 Recombinant monoclonal antibodies recognizing antigen ior c2 and the use thereof in the diagnosis and treatment of colorectal tumors |
11/08/2001 | WO2001032614A3 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
11/08/2001 | WO2001032128A3 Human chemokine beta-13 |
11/08/2001 | WO2001023414A3 Immunologically significant herpes simplex virus antigens |
11/08/2001 | WO2000006713A8 Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin |
11/08/2001 | US20010039479 Three-dimensional model of a Fc region of an IgE antibody and uses thereof |
11/08/2001 | US20010039332 Monoclonal antibodies to 4,4'-dinitrocarbanilide and a method for analyzing for the drug nicarbazin |
11/08/2001 | US20010039027 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity |
11/08/2001 | US20010039008 Immunofluorescence |
11/08/2001 | US20010038843 Immunogenic polypeptide comprising a self Immunoglobin E (IgE) portion and a non-self IgE portion, to induce an anti-self IgE response in a mammal; treating diseases such as allergies |
11/08/2001 | CA2750984A1 Porphyromonas gingivalis recombinant proteins and truncations |
11/08/2001 | CA2414775A1 A method and device for improving protein stability and solubility |
11/08/2001 | CA2407965A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
11/08/2001 | CA2407959A1 Human wingless-like gene |
11/08/2001 | CA2407956A1 Modified peptides as therapeutic agents |
11/08/2001 | CA2407887A1 Natrium-calcium exchanger protein |
11/08/2001 | CA2407746A1 Proteases |
11/08/2001 | CA2407709A1 Regulated antigen delivery system (rads) involving bacteria |
11/08/2001 | CA2407603A1 Porphyromonas gingivalis recombinant proteins and truncations |
11/08/2001 | CA2407601A1 Novel human phospholipase c delta 5 |
11/08/2001 | CA2407595A1 Mutant strains capable of producing chemically diversified proteins by incorporation of non-conventional amino acids |
11/08/2001 | CA2407435A1 Rna metabolism proteins |
11/08/2001 | CA2407219A1 Pain signaling molecules |
11/08/2001 | CA2406999A1 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
11/08/2001 | CA2406746A1 Methods and compositions for impairing multiplication of hiv-1 |
11/08/2001 | CA2400755A1 Improved e. coli extract for protein synthesis |
11/08/2001 | CA2377877A1 Immunoglobulin bonding protein arrays in plant cells |
11/07/2001 | EP1151304A2 METHOD OF IDENTIFYING N-TERMINAL proBNP |
11/07/2001 | EP1151299A1 Method of site specific labeling of proteins and uses therefor |
11/07/2001 | EP1151143A1 Selection of proteins using rna-protein fusions |
11/07/2001 | EP1151131A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
11/07/2001 | EP1151117A1 Intein-mediated protein ligation of expressed proteins |
11/07/2001 | EP1151112A1 Heat-inducible promoter |
11/07/2001 | EP1151109A1 Fucosyl transferase gene |
11/07/2001 | EP1151108A1 The ltr region of msrv-1 and the proteins it encodes, and probes and methods for detecting msrv-1 retrovirus |
11/07/2001 | EP1151107A1 Basb059 polypeptides from neisseria meningitidis |
11/07/2001 | EP1151106A2 Methods for producing polypeptides in fungal cells |
11/07/2001 | EP1151102A1 Glycosylated leptin compositions and related methods |
11/07/2001 | EP1151101A1 Prostacyclin-stimulating factor-2 |
11/07/2001 | EP1151095A1 Polypeptide variants with raised heparin-binding capacity |
11/07/2001 | EP1151012A1 Rhamm antagonist antibodies |
11/07/2001 | EP1151011A1 Anti-ccr1 antibodies and methods of use therefor |
11/07/2001 | EP1151002A1 Antibodies specific to kdr and uses thereof |
11/07/2001 | EP1150994A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
11/07/2001 | EP0912901B1 Method and reagent for monitoring blood levels of antiplatelet compounds |
11/07/2001 | CN1321195A Peptidyl prolyl cis-trans isomerases |
11/07/2001 | CN1321190A i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene |
11/07/2001 | CN1321165A Prevention and treatment of viral disease |
11/07/2001 | CN1321064A Plant resistance to insect pests medicated by viral proteins |
11/07/2001 | CN1074458C Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
11/07/2001 | CN1074422C Method for preparing HCV epitope-contg. separated polypeptide |
11/06/2001 | US6313378 Transgenic plant for use in biological pest control |
11/06/2001 | US6313281 Nucleic acid encoding OMP26 antigen from Haemophilus influenzae |
11/06/2001 | US6313276 Human endothelin receptor |
11/06/2001 | US6313269 Tumor necrosis factor related receptor, TR6 |
11/06/2001 | US6313264 Effector proteins of Rapamycin |
11/06/2001 | US6313263 γ, δ T cell receptor and methods for detection |
11/06/2001 | US6312951 Expression augmenting sequence elements (ease) for eukaryotic expression systems |
11/06/2001 | US6312922 Complementary DNAs |
11/06/2001 | US6312921 Nucleotide sequences which code preferential polyeptides; for use in diagnosis and treatment of tumors |
11/06/2001 | US6312916 Mutant polypeptide; for use in reduction of inteference associated with immunoassays |
11/06/2001 | US6312907 An isolated nucleic acid encoding a gene for decorin binding protein from borrelia; diagnosis and therapy of lyme disease in humans and animals |
11/06/2001 | US6312899 A polynucleotide probe for the detection and diagnositic staging of lymphocyte differentiation |
11/06/2001 | US6312890 Partial intron sequence of von hippel-lindau (VHL) disease gene and its use in diagnosis of disease |
11/06/2001 | US6312699 Genetic engineering of adenoviral fiber protein with caboxy end group |
11/06/2001 | US6312694 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |